TY - JOUR
KW - BMI, body mass index
KW - Body mass index
KW - CPRD, Clinical Practice Research Datalink
KW - Fracture pattern
KW - IR, incidence rate
KW - IRR, incidence rate ratio
KW - ISAC, Independent Scientific Advisory Committee
KW - Incident fractures
KW - MHRA, Medicines and Healthcare products Regulatory Agency
KW - MOF, major osteoporotic fracture
KW - NIAD, non-insulin antidiabetic drug
KW - Newly treated type 2 diabetes
KW - PY, person year
KW - T2D, type 2 diabetes mellitus
KW - Type 2 diabetes
AU - C. Sarodnik
AU - N. Rasmussen
AU - S. Bours
AU - N. Schaper
AU - P. Vestergaard
AU - P. Souverein
AU - M. Jensen
AU - J. Driessen
AU - J. van den Bergh
AD - NUTRIM Research School, Maastricht University, Maastricht, the Netherlands.
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark.
Department of Internal Medicine, Maastricht University Medical Centre+, the Netherlands.
CAPHRI Research School, Maastricht University, Maastricht, the Netherlands.
CARIM Research School, Maastricht University, Maastricht, the Netherlands.
Steno Diabetes Center North Jutland, Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.
AN - 36062034
BT - Bone Rep
C2 - PMC9437792
DO - 10.1016/j.bonr.2022.101614
DP - NLM
ET - 2022/09/06
LA - eng
N1 - 2352-1872
Sarodnik, Cindy
Rasmussen, Nicklas H
Bours, Sandrine P G
Schaper, Nicolaas C
Vestergaard, Peter
Souverein, Patrick C
Jensen, Morten H
Driessen, Johanna H M
van den Bergh, Joop P W
Journal Article
Bone Rep. 2022 Aug 22;17:101614. doi: 10.1016/j.bonr.2022.101614. eCollection 2022 Dec.
PY - 2022
SN - 2352-1872 (Print)2352-1872
EP - 101614
T2 - Bone Rep
TI - The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus
VL - 17
ER -